| Posted: |
27 Feb 2008 |
| Published: |
01 Dec 2006 |
| Format: |
PDF
|
| Length: |
142
Page(s) |
| Type: |
Product Literature |
| Language: |
English |
|
ABSTRACT:
Large pharma companies consider R&D such a defining capability, they've been hesitant to move these activities outside the firm-much less offshore. This paper addresses new market forces that are compelling them to consider a range of alternatives, including outsourcing and offshore opportunities.
|
 |
|
|
|
BROWSE RELATED RESOURCES:
Collaboration | eGovernment | Government Departments | Public Sector | RFID |
|
View All Resources
sponsored by IBM Line of Business |
 |
|
|
|
Cramsession Research Library Copyright © 1998-2008 Bitpipe, Inc. All Rights Reserved. Designated trademarks and brands are the property of their respective owners. TechTarget · 117 Kendrick St · Needham, MA · 02494
Use of this web site constitutes acceptance of the Bitpipe Terms and Conditions and Privacy Policy. cramsession@bitpipe.com
|
